Free Live Webinar and Interactive Discussion

ibiTea—A Scientific Get Together

ibidi is pleased to invite you to a new, interactive meeting format, ibiTea. First, you will attend an informative webinar presented by leading scientists and tech companies in the field of imaging and microscopy. Afterwards, you will join the presenters and other participants for a cup of tea and interesting, in-depth discussion.

These webinar meetings are set up to give you valuable information, then let you virtually interact with the speakers and ibidi experts, in order to start fruitful discussions, get more background information, or simply share your thoughts and ideas.


Join us for the first ibiTea on May 18, 2021:

Organoid Migration and High-Resolution Microscopy of 3D Structures

These topics are waiting for you:

Unravelling Behavioral-Phenotypic Heterogeneity of Cellular Immunotherapies Targeting Solid Tumors

Presented by Amber Wezenaar, Princess Maxima Research Center in Utrecht, The Netherlands.

Breast cancer organoid (membranes (F-actin) in blue and nuclei (DAPI) in grey) being attacked by T cells (membranes (CD3) in orange and nuclei (DAPI) in grey)

Gentle, 3D, Super-Resolution Live-Cell Imaging With the RCM2


Presented by Jeroen Kole, Confocal.nl.


Hatching-Mouse Blastocysts – stained for GATA4

Are you interested in participating in the first ibiTea Scientific Get Together?
Please register here.

May 18, 2021, 2 pm Munich CEST
(8 am New York EDT | 1 pm London BST) >>

Click here to check the time in your own country >>

ibiTea Topic Outline

Advancements in cellular immunotherapies, which utilize genetically engineered T cells, have shown great promise in hematological and some solid malignancies. For the first ibiTea topic, expert Amber Wezenaar will discuss using a novel, immune-organoid 3D imaging transcriptomics platform. She will show us how this platform can unravel the behavioral and underlying molecular mechanisms of an emerging cancer metabolome-targeting immunotherapy. This technique enables the characterization of behavioral-phenotypic heterogeneity of cellular immunotherapies.

A common challenge in live-cell microscopy, especially super-resolution microscopy, is that the high laser power imposed by many super-resolution techniques often causes bleaching and phototoxicity, therefore altering the biology of the cells being studied. For the second ibiTea topic, Jeroen Kole will give tips about keeping cells alive and healthy during high-resolution microscopy of 3D structures. The Re-scan Confocal Microscope 2 (RCM2) allows for the capture of 120nm resolution data, using a laser power that is a factor 1000 lower than other commonly used techniques. This technique makes the RCM2 an excellent tool for high-contrast 3D imaging of live organoids.

Speakers

Amber Wezenaar, PhD at Princess Maxima Research Center Utrecht, The NetherlandsAmber Wezenaar, PhD at Princess Maxima Research Center Utrecht, The Netherlands

Amber studied Biotechnology at the VHL University of Applied Science in the Netherlands, with a focus on immunology. In November 2019, she started working at the Princess Maxima Research Center in Utrecht and focused on her research topic, "In-depth Characterization of Cellular Immunotherapies Using 3 D Live Cells". Since Sept 2020, she has been working on her PhD, in the group of Prof. Anne Rios, on the topic, "Tumor Microenvironment Modulation T Cells Therapies Targeting Solid Tumors".

Jeroen Kole, Product Application Specialist, Confocal.nlJeroen Kole, Product Application Specialist, Confocal.nl

Jeroen studied biology at the Saxion University of Applied Sciences. After his studies, he worked at the AO2M microscopy facility at the VU Medical Center in Amsterdam for several years, before joining Confocal.nl in 2018 as a Product Application Specialist. With this background, Jeroen has extensive experience in microscopy. He is currently working with live cells on several microscopes, including widefield, confocal, STED, Lightsheet, and RCM systems, and he is also responsible for the Confocal.nl distributor network in the US.